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Antibiotic resistance is a global health problem that threatens humankind. Extensive use of 
antibiotics has led to an increase in the prevalence of resistant bacterial strains.  
 
Aims: The aim of this study is to investigate the prevalence and levels of antimicrobial 
resistance genes, i.e. cfxA and erm(B), in saliva obtained from dental students, and to assess 
the relationship between the prevalence of these genes and commitment to hygiene 
procedures and habits by dental students in the clinics. 
 
Materials and method: A questionnaire was used to report the demographic data, attitudes 
and hygiene practices of 1st- and 5th-year dental students. Together with the questionnaire 
whole saliva samples were collected from the study subjects. DNA was extracted from the 
samples followed by amplification and quantification of the resistance genes using droplet 
digital PCR (ddPCR). 
 
Results: We detected the resistance genes in almost all the participants, with cfxA detected in 
100% of the samples and erm(B) detected in 94%. However, our result suggested that there is 
no significant difference in level of resistance genes between the 1st- and 5th-year dental 
students. On the other hand, significant difference was found between participant who had a 
history of taking antibiotics in the past and levels of erm(B) resistance gene in their saliva. 
 
Conclusion: It seems that the use of saliva samples as a biological sample companied with 
the sensitivity of ddPCR could be used as a diagnostic tool to reveal the presence and levels 
of resistance genes in a given individual. It also seems that the high levels of cfxA compared 
to that of erm(B) reflect the use of β-lactam antibiotics in the society. What we still do not 
know is the clinical aspect regarding the resistance gene. At what level of a particular 
resistance gene one could predict a failure of an antibiotic treatment aiming to affect a 
bacteria with that gene. 
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1. Antibiotic resistance 
1.1. History of antibiotics 
The accidental discovery of the penicillin by Alexander Fleming in 1928 was a turning point 
in medical history that shaped the health of humankind. Its immense therapeutic potential led 
to a mass production in the 1940´s, and wide distribution of the medication. Antibiotics were 
used to cure a variety of infectious diseases affecting human and animals. However, the issue 
of antibiotic resistance became a concern right after antibiotic discovery. Some strains of 
bacteria developed mechanisms to withstand the effectiveness of antibiotics, an observation 
also made by A. Fleming, who warned against the irrational use of these drugs (1). Today, 
there are limited treatment options for bacterial infections caused by multidrug-resistant 
bacteria (MDR). The majority of the classes of antibiotics that we use today were discovered 
in the mid 20th century, and have later been chemically modified into new generation of 
synthetic and semi-synthetic drugs. 
1.2. Classification of antibiotics 
Antibiotics or antibacterial agents kill or inhibit bacteria growth. They are used to treat an 
existing bacterial infection or, less frequently, to prevent serious bacterial infections. One way 
of classifying antibiotics is by their sites of action. The five main bacterial targets sites are 
cell wall synthesis, protein synthesis, nucleic acid synthesis, metabolic pathways, and cell 
membrane function. Antibiotics that inhibit cell wall synthesis include β-lactams and 
glycopeptide antibiotics. The β-lactam antibiotics share a common molecular component, a 
four-atom ring known as β-lactam, e.g. penicillins and cephalosporins. Some antibiotics 
inhibit protein synthesis, such as tetracycline and macrolides including erythromycin. The 
nucleic acid synthesis is inhibited by quinolones and rifamycins. Antibiotics such as 
sulfonamides, trimethoprim and nitroimidazoles inhibit the synthesis of metabolites affecting 
the nucleic acid synthesis, such as folate. Other antibiotics like lipopeptides and polymyxins 
target the cytoplasmic membrane of bacteria (2). 
1.3. Antibiotic resistance 
Antibiotic resistance is the ability of a bacterium to resists the action of an antibacterial agent 
at a concentration equivalent to a normal dosage. Resistance could be due to internal 
resistance (inherited) or could be an acquired one. Acquired resistance is gained by 
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undergoing a permanent genetic change, for example through horizontal gene transfer or 
mutations that render susceptible bacteria into a resistance one (3). There are three main 
mechanisms by which bacteria can resist antibiotic agents: drug inactivation, altering target 
and altering uptake.  
1.3.1. Drug inactivation 
Resistance genes allow bacteria to produce enzymes that modify and inactivate antibiotics 
before reaching the target site. These enzymes include β-lactamases that hydrolyse the β -
lactam ring in antibiotics such as penicillin and cephalosporins (4).  
1.3.2. Target alteration 
Bacteria may also be able to alter the antibiotic target by the acquisition of genes encoding a 
different target enzyme. This mechanism leads to a lower affinity for the antibiotic and thus 
development of resistance.  
1.3.3. Uptake alteration 
Bacteria can lower the permeability of the cell wall by altering the function or numbers of 
protein structures needed by antibiotics to enter the cell. Also, the outer cell membrane of 
gram-negative bacteria has a bilayer of hydrophobic lipid bilayer creating a barrier (5). Efflux 
pumps are another bacterial defence mechanism that functions by transporting toxic 
substances out of the bacterial cell. The efflux pumps are energy dependent and may be either 
drug-specific or able to exert its function on a number of different substances. Overexpression 
of these pumps reduces the drug concentration within the cell and cause antibiotic resistance 
(6).  
1.4. Antibiotic resistance in Norway 
“Norwegian surveillance system of antimicrobial drugs resistance“ (NORM) (7) concluded in 
a recent report that antibiotic resistance is a limited problem in Norway. However, NORM 
also emphasizes that the situation may change quickly if preventive measures are not 
followed. An effective measure to reduce the occurrence of antibiotic resistance among 
bacteria is to minimise the use of antibiotics to absolute necessity. In Norway, medical 
doctors, dentists and veterinaries have the legal right to prescribe antibiotics. Dentists 
contribute with approximately 8% of the all the prescriptions in the country (8). Consumption 
of antibiotic in any society can be measured in defined daily doses (DDDs) per 1000 
inhabitants per day. The most frequently prescribed (measured in DDDs) antibiotic by 
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dentists is phenoxymethylpenicillin (it counts to 72% of all antibiotics prescribed by dentists). 
Amoxicillin and clindamycin are the second and third most prescribed accounting for 
approximately 11% and 6%, respectively. Looking at the consumption of antibiotics in 
Norway measured by DDDs for the treatment of human infections in 2014, penicillin 
accounted for 42% of total antibiotic consumption whereas tetracycline accounted for 18%. 
Macrolides (e.g. erythromycin) and lincosamides made up 9% of the total consumption (7). In 
addition to human use of antibiotics, a number of antibiotics are also used as growth 
promoters in the food industry, which is hugely disputed in the scientific community. 
1.5.  Resistance genes  
There are a number of different genes encoding resistance to the most commonly used 
antibiotics in dental practice. Genes of interest in this study were cfxA and erm(B), which 
respectively corresponds to antibiotic resistance against β-lactam antibiotics and 
erythromycin. 
 
 A number of genes encode β-lactamases, one of which is the cfxA gene. β-lactamases are 
divided into subclasses A-D, and cfxA belongs to class A utilizing serine for β-lactam 
hydrolysis. This gene is prevalent in gram-negative bacterial species (9).  
 
Erm(B) is a gene that confers resistance to the macrolide antibiotic erythromycin by encoding 
the enzyme rRNA adenine N-6-methyltransferase. This enzyme methylates adenine in a 
specific position in bacterial rRNA, hence causing an alteration of the target (10).  
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2. Oral bacteria 
The oral cavity is inhibited with diverse microflora, consisting of viruses, fungi, protozoa 
archaea and bacteria. The archaea represent only a few species while the bacteria are the 
dominating microorganisms with hundreds and probably thousands of different bacterial 
species. The bacterial communities found in the human mouth shows high complexity and is 
the second most complex and miscellaneous after the bacterial community found in the colon 
(11). In the recent years, the use of next-generation sequencing (NGS) technique allows the 
discovery of a higher number of bacterial diversity present in the mouth, and other parts of the 
human body (12). Over 600 human oral bacteria and phylotypes have been identified and 
classified into taxonomic system provided by a public available database, the Human Oral 
Microbiome Database (HOMD) (13). 
  
A mechanism that contributes to the diversity of human microflora is horizontal gene transfer 
between bacterial species. The horizontal gene transfer allows bacteria to take up DNA from 
the environment by three major mechanisms transduction, conjugation and transformation. In 
the similar way, antibiotic resistance genes are spread between bacteria, especially by 
conjugation and transformation (14). In transduction bacterial viruses (bacteriophages) take 
DNA from one cell and incorporating it into a new host cell upon infection. Conjugation is a 
transfer of DNA directly between two bacteria by specific structures in the cell membrane. 
Connection between the two bacteria is established and provides a bridge where the DNA 
from one bacterium could be exchanged to the new host. Mobile genetic elements could be 
mobile plasmids or transposons, which integrate in the host chromosomes by recombination. 
Transformation is when bacteria take up DNA directly from the surrounding environment 
(15). It involves binding of DNA to the cell surface, transfer one strand of the DNA across the 
cell membrane and integrate the new DNA through recombination to chromosomal DNA. The 
ability to transfer DNA between oral bacterial strains promotes a better adaption to the 
environment of the mouth and improves the survivability of the bacteria (14). 
2.1. The mouth as a habitat 
The oral cavity is warm and moist and provides favourable growth conditions for different 
microorganisms. This is reflected in the rich diversity of microorganisms found in the oral 
cavity. Saliva is helping to maintain the oral pH in neutral level, which is suitable for the 
growth of many microorganisms. In general, the mouth is aerobic. However, the oxygen 
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which is present is rapidly used by early colonizers that are aerobic or facultative anaerobic, 
in this way making conditions more appropriate and suitable for obligate anaerobes (12). 
Obligate anaerobes are especially found on tooth surfaces in dental plaque biofilms, hosting 
acidogenic and aciduric bacterial species. The oral cavity itself is a major source of nutrition 
with endogenous and exogenous nutrients, suitable for bacterial growth. Endogenous nutrients 
like peptides, proteins and glycoproteins are found in saliva and gingival crevicular fluid, 
while the exogenous nutrients originate from the daily dietary intake. Despite a wide-range of 
diet, the fermentable carbohydrates are the only class of nutrients that influence the microbial 
ecology within the mouth (16).  
3. Oral Biofilm 
To understand the role of the oral bacteria in health and disease it is essential to view the 
microbial community as one entity. Communities in oral cavity appear as microbial biofilms 
on teeth surfaces, mucosal surfaces, gingival crevices and tongue, all in contact with saliva. 
Biofilms are highly organized matrix-enclosed communities of microorganisms that develop 
on different surfaces, with constituent organisms becoming phenotypically distinct from their 
unattached counterparts (17, 18). Several studies have shown that the composition of the 
microflora, which constitutes the biofilm, varies remarkably at different oral structures and 
sites (19-21). The development of microbial community begins with adhesion of early or 
primary colonizers to a surface. The early colonizing organisms then provide a new surface 
and more favourable conditions for succeeding organisms to attach.  Primary and early 
colonizers in the oral cavity often include Streptococcus and Actinomyces species. These 
provide a conditioning film for the subsequent early colonizers, such as Veillonella and 
different strains of Actinomyces and influence the succeeding stages of biofilm maturation 
(18, 22, 23).  
 
Initial adhesion of bacteria to dental surfaces is mediated by saliva components adsorbed by 
these surfaces. These molecules are primarily originating from saliva, but in the subgingival 
region molecules derived from gingival crevicular fluid have also been documented (24).  The 
different surfaces present different salivary receptors and, therefore, the specific components 
adsorbed will depend on the surface composition (18). Molecules are adsorbed to the distinct 
surfaces within seconds, immediately after exposure to the oral environment. Primary 
colonizers adhere to the surface initially by weak and reversible adhesion. Subsequently, 
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irreversible and strong adhesion is established between specific molecules on the microbial 
cell surface, called adhesins, and complementary molecules called receptors, present in the 
conditioning film. Later on, further accumulation of bacteria will occur by co-adhesion. 
Secondary and late colonizers adhere when cell surface adhesins are binding to new receptors 
provided by attached bacteria. The attached bacteria will multiply and increase the volume of 
the biofilm and exopolymers are synthesised forming biofilm matrix, enclosing the 
components into a biological community (12).  
 
The extracellular matrix in biofilms mainly consists of water and macromolecules derived 
from microbes. The matrix provides architectural structure and mechanical stability to 
attached bacteria. The matrix structure and integrity is severely influenced by the surrounding 
macro-environment. The biofilm matrix is constantly undergoing changes, regularly replacing 
exopolymers and resident cells. Hence, biofilm matrix is considered as a dynamic 
heterogeneous system (25, 26). Additional to work as a three-dimensional network it also has 
a protective role, by protecting resident cells against antimicrobial agents. The matrix works 
like a physical barrier, preventing entry of those agents into the microbial community.  
 
Bacteria have their own communicating system called quorum sensing, which includes 
expression of large number of genes called autoinducers, according to density of the bacterial 
population. Quorum sensing allow bacteria to regulate a variety of physiological functions 
and it is an important strategy in bacterial communities to regulate biofilm formation, 
expression of virulence factors and antibiotic resistance to mention a few (27). 
 
It is not surprising to know that commensal and potentially pathogenic bacteria might coexist 
in oral microbial communities, and their counts and relative proportion could determine the 
presence or absence of health and disease. Most of the oral bacteria are considered to be a part 
of the commensal flora, relatively harmless, providing benefits for the host. When changes in 
the environment occur, bacteria considered to be a part of the commensal flora could show 
opportunistic behaviour and, therefore, acting pathogenic. This behaviour often appears when 
the homeostasis, which exist between commensal flora, is interrupted, for example by 
inflammation or by the use of antimicrobials. Certainly, most of the people got periods in 
their life suffering from localized episodes of disease in the mouth caused by imbalances in 
their resident oral microflora (16). The most common diseases caused by oral bacteria are 
dental caries and periodontal diseases.  
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4. Use of personal protective equipment in dental practice 
Genetic material such as genes encoding antibiotic resistance can be exchanged between 
bacterial populations colonizing in the same environment. As a dentist or dental student, you 
have to be aware of transmission routes for infecting strains when treating patients. You also 
need to obtain knowledge about how to get infection control, by prevention. In dental 
practice, interaction with the patients, the use of rotary instruments such as handpiece, and 
ultrasonic scalers create a risk of catching a visible or invisible droplet of e.g. saliva, blood, 
microbes or aerosols spread in the working surrounding area. These droplets could also settle 
in a short distance on nearby dental equipment, on the dentist cloths, other dental health care 
personnel or the patient. To avoid widely distribution of infectious agents that could carry 
resistance genes, dental students and dentists are obliged to work with good hygiene habits 
and always use personal protective equipment in the clinic to achieve optimal infection 
control conditions.  
 
Before treating the patient, the dentist should perform a thorough hand wash with soap, 
followed by hand disinfection. When treating the patient, the dentist should always wear 
gloves, surgical mask, protecting eyewear and protective clothes as a standard of care during 
dental treatments. The gloves and the surgical mask should be changed between different 
patients or during the treatment procedure if the gloves tears, or if the mask becomes wet. 
Also, the eyewear should be gently cleaned with water and soap, and disinfected between 
patients. Occasionally, protective eyewear should also be offered to the patient. The scrubs 
should be changed daily, or when leaving the clinic. The personal protective equipment works 
as a barrier to protect the skin and mucosal surface of eyes, nose and mouth when exposed to 
potentially infectious microbes during dental treatment. This is of great importance to prevent 
contamination from saliva, blood, and any potential infectious agent between patient and 
dentist (28). 
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5. Saliva 
5.1.  Function 
Human saliva consists mostly of water (over 99%), but also contain important substances both 
inorganic and organic, such as electrolytes, proteins, glycoproteins and enzymes (29). Saliva 
has many beneficial functions and plays an important role in the maintenance of oral health. 
Saliva is secreted by major and minor salivary glands and is produced by clusters of cells 
called acini. They produce the glycoprotein mucin, which is the main component in mucous 
that lubricates and helps with swallowing, mastication and speech (29). Saliva also allows us 
to taste by acting as a solvent for taste substances. Enzymes in saliva already start the 
digestion process in the mouth and brakes down starch. It also protects us from harmful 
components, by rinsing and removing microorganisms and food from the oral cavity (29). 
Immunoglobulins, mainly IgA, are produced by plasma cells in the salivary glands and 
provide a more specific bacterial defence. By buffering action, saliva neutralizes acids in the 
mouth (29). 
5.2. “Dry mouth” 
Xerostomia is defined as a subjective feeling of oral dryness and often just described as 
having a “dry mouth”. Hyposalivation, on the other hand, is based on an objective 
measurement of the saliva flow. Salivary gland hypofunction is a term that can be used to 
cover both subjective symptoms and objective signs of dry mouth (29). Some of the major 
risk factors developing salivary gland hypofunction are the use of medication, Sjogren´s 
syndrome and radiation treatment associated with cancer therapy.  More than 500 types of 
medication have xerostomia as a possible side effect and especially a combination of several 
drugs can cause difficulties with dry mouth (30, 31). According to studies, elderly people 
more often have a reduced saliva secretion (32). The reduced production of saliva impairs oral 
functions and also increases the risk of caries, oral candidiasis and other diseases. Dry mouth 
is often reported after a 50 % reduction in saliva secretion (29).  
5.3.  Saliva flow rate test 
Saliva is produced by three major salivary glands submandibular, sublingual and parotid 
glands in addition to many minor salivary glands. Saliva secreted in association with food 
intake is produced mainly in the parotid glands. Saliva flow rate can be measured with a 
stimulated saliva test. While chewing a piece of paraffin, saliva is collected in a collection 
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tube for 5 minutes (33). According to the clinical reference values used by the dental education 
in Tromsø, normal secretion is in the range of 1,00 – 3,00 ml/min, whereas low variation is 
between 0,70 – 1,00 ml/min. Low secretion/hyposalivation is secretion of less than 0,70 ml/min of 
saliva (34). The saliva test is a diagnostic tool, but even though a low secretion is measured it 
does not necessarily mean the subject is experiencing having a dry mouth. Also, those 
experiencing xerostomia might secrete normal amounts of saliva (33). Thus, a careful oral 
examination is necessary supplement to identify people with reduced saliva secretion. 
5.4. Saliva fluid as a diagnostic fluid 
Saliva can easily be collected non-invasively using simple equipment. Compared with blood 
samples there is no need for trained technicians to do the collection and the procedure is pain-
free (35). Whole saliva is most frequently collected for clinical analysis, but saliva can also be 
collected directly from a specific salivary gland. Whole saliva also contains microorganisms, 
gingival crevicular fluid, a mixture of substance from the airways and gut, food debris and 
systemic substances. This is why saliva has been stated to be a reflection of the body (36). 
Dentists can assess caries risk factors by salivary analysis determining the saliva rate, buffer 
capacity and by detecting the amount of Lactobacilli and Streptococcus Mutants. Other areas 
of use are the detection of biomarkers such as hormones and antibodies. Measurements of 
salivary cortisol levels are used in diagnosing Cushing's syndrome (37) and oral tests 
detecting antibodies to Human Immunodeficiency Virus (HIV) are currently on the marked. 
6. Polymerase chain reaction (PCR) 
The polymerase chain reaction (PCR) is a technique that allow us to generate large amounts 
of specific sequences of DNA, which otherwise would be too small to detect. The segment to 
be amplified is called the template and a great number of copies, called amplicons, can be 
generated through repeated thermal cycles of denaturation, annealing and extension. 
Denaturation at a temperature of about 94-98°C separates the DNA double helix in two 
complementary strands. During annealing, cooling to around 50-65°C degrees allows primers 
(short nucleotide sequences of about 20 base pairs) to hybridize to the single stranded DNA in 
each end marking the starting point of the replication. A probe is a signal molecule that binds 
between the primers and emits fluorescence when the replication is complete. During 
extension the enzyme DNA polymerase synthesizes a complementary DNA strand from the 
3`-end to the 5`-end of the strand by adding free nucleotides. Repeated cycles gives an 
exponential growth of the PCR product. 
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7. The aim of our study 
We know today that bacteria and resistance genes are being exchanged between different 
communities, individuals, and bacterial population. Despite good hygiene habits, 
dentists/dental students have an increased risk of contamination because they work closely 
with infected people and use equipment that can help microbe to spread in the working 
environment such as handpiece. Based upon this, our hypothesis is that 5th-year students have 
higher levels of resistant genes in their saliva compared to 1st-year students. The aim of the 
current study is to investigate the occurrence of antimicrobial resistance genes in saliva 
obtained from dental students and to assess the relationship between the prevalence of these 
genes and commitment to hygiene procedures and habits by dentists/dental students in the 
clinics. We also want to assess knowledge and attitudes among dental students related to the 
use of protective equipment to achieve optimal infection control measures. It is unknown how 
frequently resistant genes occur in the saliva among our study population and which factors 
could contribute to the spread of resistance. In other words, is the prevalence and levels of 
resistance genes found in saliva depending on how long the dentist/dental student has been 
working in the clinic? 
8. Materials and methods 
1st-year dental and medical students and 5th-year dental students attending their studies and 
clinical practice at the Department of Clinical Dentistry, UiT The Arctic University of 
Norway were invited to participate voluntary to the study. After getting a proper consent, 
participants that fulfil the inclusion criteria were asked to donate a saliva sample and to 
complete a questionnaire on their demographic data and, where applicable, questions on 
commitment to proper hygiene practices at the clinic were also included. The Regional 
Committee for Ethical approval of North-Norway approved the study protocol and procedures 
to obtain saliva samples prior to the study (Reference number: 2015/1048/REK-nord). 
8.1. Collecting saliva samples 
8.1.1. Study population 
Whole saliva specimens were collected from dental and medical students, attending education 
programs at UiT - The Arctic University of Norway. Medical students were invited to attend, 
as they have the same curriculum as the dental students in the first year of their education, and 
thus considered to be similar to 1st -year dental students. The dental education is a 5-year 
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master programme. The first two years the students are in a preclinical phase and are taught in 
basic sciences such as biochemistry. Third year the dental students are introduced to the clinic 
and patient care. Samples were collected from 1st-year students, attending either dental or 
medical studies and who have no contact with patient clinics at this stage of their education. 
The 5th year students came from two different graduating classes (graduating in June 2015 
and June 2016). Subjects in both classes had at least 18 months of experience in patient 
treatment at dental clinics. All study subjects presented with general good health prior to the 
sample collection. The exclusion criteria were any antibiotic therapy within the three last 
months or any systematic disease that could influence the composition of oral bacteria.  
8.1.2. Consent 
The participants were asked to sign a consent form prior to the collection of saliva (see 
Appendix I). The consent form contains information about the study aims and how saliva 
sample will be collected, used, stored and dealt with during and after the study.  
The participants were informed that the collected data will be treated confidentially, and 
participants will remain anonymous in any form of report of study findings.   
8.1.3. Saliva sample collection 
Each study subject donated a whole saliva specimen using a test for stimulated saliva. The 
participants were informed about the procedure of collecting saliva beforehand in a separate 
session, and the information was also stressed prior to the sample collection. The subjects 
were informed not to eat, drink, or use any form of nicotine within the last hour prior to 
sampling. The specimen collection was done in a quiet room available for students at the UiT 
The Arctic University of Norway. The subjects were relaxed and calm during the procedure. 
The participants were sitting in an upright position with the head inclined forward. To 
stimulate saliva secretion, the students were given a piece of sterile paraffin wax to chew on 
for approximately 30 seconds before the collection of saliva. Then the participants were 
spitting saliva frequently into a sterile collecting tube for five minutes. Saliva sample was 
then stored in -80°C freezer for further analysis. 
8.1.4.  Questionnaire  
The participants were asked to answer a questionnaire concerning their general health, use of 
antibiotics and other medications in the past, and use of tobacco. They were also asked 
questions about their dental health, oral hygiene practices and their personal hygiene. The 
questionnaire also investigated commitment to hygiene practices in the dental clinic and 
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attitudes and knowledge related to infection control measures. In addition, knowledge about 
how to clean and disinfect instruments and other equipment, and how to use protecting 
supplements to prevent infection at the clinic were also investigated. The questionnaire 
comprised of 34 questions for the 5th year dental students and only 22 questions for the 1st 
year students (See Appendix II). 
8.2. Laboratory analysis 
8.2.1. Saliva inspection 
The graduated test tubes containing saliva samples were visually inspected. The amount of 
saliva was compared to the reference values represent normal amount of saliva secretion. 
According to the reference values, saliva samples containing less than 5,0 ml were considered 
as being in the low secretion range. Samples containing 5,0 ml or more were considered to be 
in the normal range.  
8.2.2. Bacterial DNA extraction 
Bacterial DNA was extracted using QIACube and QIAamp ® DNA Mini Kit (QIAGEN). In 
brief, a total of 500-800 µl of saliva were transferred to sterile Eppendorf tubes and were 
diluted with equal amount of Dulbecco’s Phosphate Buffered Saline (PBS)(Sigma® Life 
Science. The tubes were centrifuged for five minutes at 21100 G to pellet bacteria. After 
centrifugation, the excess fluid was discarded in each tube. Automated DNA extraction in 
QIACube was performed by using QIAamp ® DNA Mini Kit with a proper extraction 
protocol according to the manufacturer’s instructions for isolation of bacterial DNA from 
body fluids. At the end of the extraction procedures, DNA samples were eluted in 50µl of TE 
buffer. 
8.2.3. Agarose gel-electrophoresis 
The yield of DNA extraction was checked with agarose gel-electrophoresis. Visualization of 
extraction bacterial DNA from saliva was done in 1 % agarose gel to confirm whether the 
extraction succeeded, or not. Agarose gel was prepared, by dissolving agarose powder 
(Amresco®, VWR) in TAE (Tris-acetate-EDTA) buffer. Nucleic acid stain GelRedTM Nucleic 
Acid (Biotium) was used to stain DNA in the agarose gel. GelRedTM is a fluorophore that 
binds DNA, and when excited with UV-light it will fluoresce. In brief, DNA samples were 
prepared as follows: A total of 10 µl of extracted DNA is mixed with 2 µl of 6x Gel Loading 
Dye Blue (New England BioLabs, UK). Then 10 µl of the mixture was loaded on the gel. 
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Also, 10 µl of 1kb DNA Ladder (New England BioLabs, UK) was also loaded in a separate 
lane in the gel to act as a molecular weight reference for DNA size. The 1kb DNA ladder 
contains bands ranging from 0,5 to 10 kilobases (kb). The agarose gel was run at 100V for 
approximately 50 minutes. The gel was then visualised with UV-trans-illuminator in the gel 
documentation system ChemiDocTMTouch Imaging System (Bio-Rad). 
8.2.4. Measurement of extracted DNA concentration 
The DNA concentration after DNA extraction was measured using Qubit Fluorometric 
(ThermoFisher Scientific). Quantitation method was done according to the manufacturer’s 
protocol. In brief, Qubit® working solution was made by mixing 1µl Qubit® ds DNA HS 
reagent with 199 µl Qubit® ds DNA HS buffer. Approximately 10µl of extracted DNA and 
10µl of the DNA standards from the kit (Qubit® ds DNA HS Standard #1and #2) were mixed 
with 190 µl Qubit working solution in small tubes and then vortexed and incubated for 2 
minutes prior to the measurement of DNA concentration.  
8.2.5. Droplet Digital PCR (ddPCR) 
Extracted DNA samples were tested for the presence of antibiotic resistance genes by using 
Droplet Digital PCR (ddPCR) system (QX200 ddPCR system, Bio-Rad). The ddPCR mixture 
consists of 10 µl ddPCR™ Supermix for Probes (no dUTP), 1 µl of each DNA Probe (Table 
1), 1 µl of diluted DNA sample and the mixture is adjusted to 20 µl reaction mix with 
molecular biology grade sterile water (Sigma ® Life Science). In ddPCR, each sample will be 
divided into approximately 20 000 small droplets. In brief, a total of 8 ddPCR mixtures 
representing 8 different samples were transferred to a DG8 cartridge and 70 µl of droplet 
generation oil for probes (Bio-Rad) was added for each ddPCR mixture in the same cartridge. 
The DG8 cartridge was then covered by a DG8-gasket and placed in Droplet Generator (Bio-
Rad) to generate droplets (Figure 1). 
 Sample preparation 
Figure 1. Illustrates sample preparation. Picture adopted from Droplet Digital 
TM PCR Applications Guide (Bio-Rad) 
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The droplet generator “use specially developed reagents and microfluids to partition each 
sample into 20 000 nanoliter-sized droplets, and the target and background DNA are 
distributed randomly into these droplets during the partitioning process” (38).When droplets 
were made, 40 µl of each PCR sample was then transferred into a 96-well microtiter plate and 
sealed with a perusable foil using a plate sealer (PX1TM PCR Plate Sealer, Bio-Rad) at 180°C. 
The PCR amplification is carried out within each droplet, using a Thermal Cycler (C1000 
Touch ™ Bio-Rad). The DNA amplification protocol that was used started with preheating 
and enzyme activation at 95°C for 10 min, followed by amplification using the following 
conditions: denaturation at 95°C for 30 s, annealing and extension at 58°C for 1 min. In total 
40 cycles were performed, followed by enzyme deactivation at 98°C for 10 min (39). Initially, 
the amplification procedure was optimized by running a temperature gradient PCR ranging 
from 55°C to 59°C. At 58 °C, the sample achieved satisfying separation between negative and 
positive droplets. Therefore, this temperature was selected when analysing the extracted DNA 
from saliva samples. When PCR amplification was complete, the plate containing the droplets 
was placed into a droplet reader (Droplet Reader QX200™ Bio-Rad), which analyse each 
well individually. The generated data were directly transferred into QuantaSoftTM software, 
where positive and negative droplets were counted and copy number of the target DNA is 
calculated statistically using Poisson distribution. Figure 2 illustrates the ddPCR workflow. 
 
 
Figure 2. Illustrates the workflow when running ddPCR. Picture adopted from Dropet Digital TM PCR 
Applications guide (Bio-Rad) 
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Table 1. Presents the genetic targets used in the current study, their function, the PCR primers and probes used 
in these targets, and the amplicon size in PCR amplification.. The yellow sequence is the forward primer (F), the 
green sequence the reverse primer (R), and the blue is the probe (P). 
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8.2.6. ddPCR Data Analysis 
The software QuantaSoftTM is used to analyse the data obtained from the droplet reader. The 
software used a two-colour detection system, measuring the number of positive and negative 
droplets for each fluorophore in each sample. Two channels in the QX200 is used to detect 
fluorophores i.e. FAM and HEX. These two channels were used to detect the presence of the 
resistance genes in our study. The erythromycin resistance gene erm(B) was detected in the 
FAM channel while the β-lactamase resistance gene (cfxA) was detected in the HEX. 
Detection of the presence of fluorescence in the two channels is then performed for each 
droplet. The number and intensity of positive and negative droplets are shown in 1-D and 2-D 
plot. Poisson algorithm is used then to report the concentration of each genetic target as 
copies/µl of the final 1x ddPCR reaction (38). 
8.3. Statistical analysis 
The data obtained from the ddPCR as well as the data obtained from the questionnaire were 
analysed by SPSS Statistical software v22.0 for any significant difference between the study 
subjects using the nonparametric Mann-Whitney U Test. 
8.3.1. Variables retrieved from the questionnaire  
Variables for descriptive statistics were retrieved from the questionnaire. They are: gender, 
year of birth, year of study, general health state, oral health state, a total of antibiotic-courses 
taken, presence of a chronic disease, smoking status, smoking duration, snuff user status, 
tobacco use and duration, count of daily cigarettes/snuff portions, frequency of teeth brushing, 
frequency of interdental cleaning appliances use, hand washing after phone usage in dental 
clinic, hand washing after filling in ambulatory medical card in dental clinic, hand washing 
after performing X-ray examination in dental clinic, hand washing after each patient in dental 
clinic, hand washing before each patient in dental, propensity to minimize hand washing in 
dental clinic, age. Initially nominal variable retrieved from question number 8 in the 
questionnaire was converted into a categorical variable comprised of the following categories: 
0 – none, 1 – antihistamines, 2 – oral contraceptives, 3 – drugs for treatment of colitis, 4 – 
thyroid hormones, 5 – immune-modulators, 6 – several drug entities.  
 
The participants reported a commercially available mark of drug for open-ended question 8 in 
the questionnaire, if applicable. Among these answers were following pharmaceutical names: 
"Levaxin", "Mercilon", "Microgynon","Cerazette","Loette", "Colazide", "Grazax", "Aerius", 
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"Zyrtec", and "Zetirizine". In addition some of participants provided answers containing 
application of a therapeutic agent, e.g. antihistamines and oral contraceptives, without using 
their commercial names. Nominal variable were converted into category variable sorting the 
drugs according to pharmaceutical registry (40) with following categories: (I) thyroid 
hormones, (II) drugs for colitis treatment, (III) oral contraceptives, (IV) immune-modulators, 
and (V) antihistamines. 
8.3.2. Variables retrieved from laboratory work  
The resulting figures retrieved from the laboratory work were: (1) absolute number of 
resistance genes (either cfxA or erm(B)) copies in each sample, reported as gene copy number 
per 1 µL of sample analysed, (2) absolute number of 16S rRNA gene in sample reported as 
gene copy numbers per 1 µL of sample analysed, (3) the concentration of DNA samples was 
reported as nanogram per microliter of the sample. The results were directly transferred from 
the QuantaSoftTM software output (readings in the column "CopiesPer20uLWell") to the 
SPSS file. The outcome variables to report were as follows: (4) relative copy number of 
resistance genes reported as number of genes per 106 copies of 16S rRNA genes, and (5) a 
relative copy number of resistance genes reported as number of genes per 1 nanogram of total 
DNA analysed. 
 
The laboratory results (1) and (2) were adjusted for dilution of the original sample of 
extracted DNA. Some of the initial DNA samples had 500-fold dilution prior to ddPCR. 
Therefore, (1) and (2) from QuantaSoft readings were multiplied by the dilution factor in 
order to refer to the initial DNA sample concentration. 
 
To compute the outcome variable (4) the following formula was used:  
relative copy number of resistance genes1 = !"#$%&'(	*&+"(,	$-	,(#.'!*'	/(*(	0$1.(#
2
!"#$%&'(	*&+"(,	$-	345	6789	/(*(3  × 10
6 
 
The reason for computing the new (4) variable is that the outcome will represent the number 
of copies of cfxA and erm(B) genes attributed to the bacterial community in the mouth. In 
contrast, the outcome variable (5) shows number of copies of resistance genes attributed to all 
                                                
1 number of cfxA or erm(B) gene per 106 copies of 16S rRNA gene 
2 cfxA or erm(B) gene copy number per 1 µL of sample analysed 
3 16S rRNA gene copy numbers per 1 µL of sample analysed 
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DNA extracted from saliva. The latter may include DNA, which originates from bacteria, 
viruses, fungi etc. 
 
To compute the outcome variable (5) the following formula was used: 




In order to perform the parametric statistical tests without violating the assumptions, the 
outcome variables (4) and (5) were undergone log10 transformation for further statistical 
analysis. Accordingly, any differences in copy numbers of cfxA and erm(B) genes between the 
1st- and the 5th-year dental students were compared using the Mann-Whitney U test. 
  
                                                
4 Number of the gene per 1 ng of total DNA analysed 
5 Resistance gene copy number per 1 µL of sample analysed 
6 Nanograms of DNA per 1 µL of sample analysed 
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9. Results  
9.1. Saliva sample collection 
Whole saliva specimens were collected from 97 subjects. 14 subjects were excluded because 
of recent use of antibiotics within the last three months. A total of 83 subjects fulfilled the 
inclusion criteria, of which, 41 samples were collected from 1st-year students, both dental and 
medical students. A total of 42 samples were collected from 5th-year students (dental 
students). The 5th-year students came from two different graduating classes (graduating in 
June 2015 and June 2016). The volume of the saliva samples was visually evaluated by using 
the gradient marks on the test tubes and compared to the reference values. A total of 96 out of 
97 samples had volumes above the threshold (5,0 ml) and were considered to have a normal 
secretion in the range of 1,00 – 3,00 ml/min. Only 1 sample had a value beneath the lower 
threshold (5,0 ml). These values were as expected, the participants in this study are relatively 
young and in good general health, with a low consumption of medications, which might 
influence the secretion.  
9.2. Questionnaire 
All the subjects presented with general good health. All the subjects were in the age group of 
19-35 years old. The mean age of the subjects was 22 years in the group of 1st-year students 
and 26-years old in the group of 5th-year students. In total 27 % boys and 73 % girls were 
recruited from the 1st-year students. The correspondent figures for the 5th year students were 
21 % and 79 %. The demographic characteristics and answers to the different questions in the 
questionnaire of the study subjects are shown in Table 2.  
 
When we investigated the infection control practices in the clinic it revealed that the 5th-year 
students have a general good knowledge and practices in these issues. Figures 3-5 (see below) 
are illustrating a selection of the data set from the questionnaire, which reflects the 5th-year 
students’ knowledge regarding infection control and hygiene in the clinic.  
 
Significantly more 1st-year students (19.5%) reported that the status of their dental health 
"neither good nor bad, (statistically significant, Pearson Chi-Square test, p-value=0.010). The 
majority of respondents reported no use of any medications on a regular basis (62.7%). Use of 
oral contraceptives was as twice as high in the 5th-year females (33.3%) compared to females 
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in the 1st-year group (14.6%) (statistically significant, Pearson Chi-Square test, p-
value=0.041). 
Table 2. Comparison of 1st- and 5th-year students regarding their answers to the different questions included in 
the questionnaire. 








Females 30 (73.2%) 33 (78.6%) 63 (75.9%) 




Very good 5 (12,2%) 17 (40,5%) 22 (26,5%) 
Good 27 (65.9%) 23 (54.8%) 50 (60.2%) 
Neither good nor 
bad 
8 (19.5%) 2 (4.8%) 10 (12%) 




Very good 22 (53.7%) 24 (57.1%) 46 (55.4%) 
Good 17 (41.5%) 17 (40.5%) 34 (41.0%) 
Neither good nor 
bad 
2 (4.9%) 1 (2.4%) 3 (3.6%) 




Never 3(7.3%) 5(11.9%) 8(9.6%) 
Seldom 22 (53.7%) 25 (59.5%) 47(56.6%) 
Occasionally 12 (29.3%) 12 (28.6%) 24 (28.9%) 
Often 4 (9.8%) 0 (0%) 4 (4.8%) 




Very satisfied 17 (41.5%) 17 (40.5%) 34 (41.0%) 
Fairly satisfied 22 (53.7%) 24 (57.1%) 46 (55.4%) 
Rather dissatisfied 2 (4.9%) 1 (2.4%) 3 (3.6 %) 





None 31 (75.6%) 21 (50.0%) 52 (62.7%) 
Oral contraceptives 6 (14.6 %) 14 (33.3%) 20 (24.1%) 
Antihistamines 3 (7.3%) 1 (2.4%) 4 (4.8%) 
Immune-
modulators 
1 (2.4%) 0 (0%) 1 (1.2%) 
Thyroid hormones 0 (0%) 2 (4.8%) 2 (2.4%) 
Adrenomimetics 0 (0%) 1 (2.4%) 1 (1.2%) 
More than 1 drug 0 (0%) 3 (7.1%) 3 (3.6%) 
Total amount of antibiotic 
courses in life 
Never 10 (24.4%) 1 (2.4%) 11 (13.3%) 
1-2 courses  13 (31.7%) 20 (47.6%) 33 (39.8%) 
3-10 courses 15 (36.6%) 15 (35.7%) 30 (36.1%) 
More than 10 
courses 
3 (7.3%) 6 (14.3%) 9 (10.8%) 
 






Figure 4. Displays knowledge and attitudes regarding single precautions in dental 
clinic 
 
Figure 3. Reflects attitudes among the students regarding the ability to protect 
himself/herself as a dentinst against contamination 
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Figure 5. Presenting attitudes and knowledge among students concerning 
impairment of good hygiene in the clinic 
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9.3. Bacterial DNA extraction 
Initially, the volume of saliva used to extract DNA was 500 µl. This was later adjusted to 800 
µl after evaluation of the extraction product to ensure a sufficient amount of DNA. 
9.4. Gel-electrophoresis 
The presence of DNA and its molecular size were verified by gel electrophoresis. One sample 
was re-extracted after detecting low fluorescence intensity. After the second extraction, the 
amount of DNA obtained from the sample was adequate. 
  
 
Figure 6. Agarose gel that shows DNA yield after DNA extraction 
9.5. Measurement of DNA-concentration 
The concentration of DNA after extraction was measured using Qubit Fluorometric 
(ThermoFisher Scientific). The DNA concentrations obtained of all the samples are presented 
in Table 3.  
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Table 3. Concentrations of extracted DNA in ng/µL obtained from all saliva samples 
Sample ID Concentration 
ng/µL 
Sample ID Concentration 
ng/µL  
Sample ID Concentration 
ng/µL  
A1 5,1 B13 44,2 B45 40,6 
A2 8,2 B14 33,8 B46 26,2 
A3 7,0 B15 11,4 B47 40,0 
A4 11,8 B16 8,0 C1 7,8 
A5 2,7 B17 7,3 C3 10,0 
A6 8,9 B18 5,2 C4 9,6 
A7 40,8 B20 8,8 C5 59,6 
A8 46,9 B21 9,0 C6 10,2 
A9 16,0 B22 6,6 C7 10,4 
A10 5,1 B23 9,6 C8 12,0 
A11 18,9 B24 10,6 C9 48,2 
A15 1,2 B25 6,8 C10 30,0 
A16 1,4 B26 9,4 C11 10,4 
A17 6,0 B27 9,9 C12 11,0 
A18 4,2 B29 7,4 C13 10,2 
A19 6,1 B30 39,4 C14 10,2 
A21 2,1 B31 14,8 C15 37,4 
A22 4,1 B32 19,6 C16 11,6 
B1 11,1 B33 17,8 C17 18,7 
B2 13,0 B34 12,0 C18 77,0 
B3 14,8 B35 10,1 C19 29,6 
B4 11,7 B36 34,8 C21 33,4 
B5 13,9 B37 9,2 C23 12,1 
B6 8,0 B38 6,9 C24 20,0 
B7 4,8 B39 11,8 C25 14,5 
B8 5,3 B40 4,3 C27 32,8 
B9 4,0 B41 36,4 C28 22,0 
B12 17,7 B42 10,6   
(Sample A12, A13, A14, A20, B10, B11, B19, B28, B43, B44, C2, C20, C22 and C26 were excluded from the 
analysis because of recent use of antibiotics within the last three months) 
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9.6. Droplet Digital PCR (ddPCR) 
In the ddPCR, droplets are made in Droplet Generator (BioRad), then amplified before 
reading them in the Droplet Reader (BioRad). The Quantasoft Software is used to analyse 
data obtained from the droplet reader. Positive droplets, which contain at least one copy of the 
target DNA molecule, exhibit increased fluorescence while negative droplets do not. Figure 7 
and 8 represent 1-D plot of positive and negative droplet separation of erm(B) and cfxA, 
respectively, of 8 DNA samples. Droplets that are located above the purple threshold line are 
designated as positive ones and all droplets located below the threshold line are designated as 
negative droplets. The threshold was set at 5000 amplitude intensity for erm(B) and cfxA, 
respectively, as droplets showed satisfying separation between negative and positive droplets 
above and under this chosen threshold.  
 
Figure 7. 1-D plot of 8 samples tested for the presence and level of erm(B) by 
the use of FAM-tagged probe. The plot illustrating positive droplets located 
above the purple threshold line, and negative droplets below that line. 
 
 
Figure 8. 1-D plot of 8 samples tested for the presence and level of cfxA by the 
use of HEX-tagged probe. The plot illustrating positive droplets located above 
the purple threshold line, and negative droplets below that line. 
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The data obtained form the ddPCR from an experiment can be also llustrated in a 2-D plot. 
Figure 9 is a 2-D plot  of cfxA and erm(B) detected in one sample. Droplets were plotted in 4 
clusters. These are FAM negative and HEX negative (double-negative droplets), FAM 
positive HEX negative FAM negative and HEX positive, and finally FAM positive and HEX 
positive (double-positive droplets).  
9.7. Data analyses 
Data obtained from the ddPCR experiments for the 83 subjects are presented in Table 4. The 
data is presented as the level of cfxA and erm(B) genes detected per 1 ng of DNA obtained 
from saliva. We also report the level of these resistance genes among the tested samples in 
relation to the total bacterial population using 16S rRNA gene as a measurement unit for 
counting bacterial species present in saliva. The statistical analysis reveals no significant 
difference between the 1st- and 5th-year dental students in the presence of the two resistance 
genes (P >0,05). More specifically, there was no significant difference in copy number of 
cfxA per ng DNA between the two groups (p=0,655). The difference in the copy number of 
erm(B) per ng DNA between the groups is not statistically significant and gave a p-value of 
0,927. Comparing the copy numbers of resistance genes cfxA and erm(B) per 106 bacteria 
between the two study groups was found not statistically significant as well.  
 
Figure 9. 2-D plot with droplets clustered at 4 different groups representing FAM negative, 
HEX negative (double-negative droplets, lower lift cluster), FAM positive, HEX negative (upper lift 
cluster), FAM negative, HEX positive (lower right cluster), and FAM positive, HEX positive (double-
positive droplets, upper right cluster)  
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The level of resistant genes in saliva per 106 copies of 16S rRNA and per one nanogram (ng) 
of DNA for cfxA and erm(B) is shown in Table 4. In addition, Figures 10 to 13 illustrate the 
distributions of the log transformed data of the total amount of cfxA and erm(B) found in the 
1st-year and 5th-year students per 106 copies of 16S rRNA and per 1 ng of DNA. 
 
Table 4. Median values of resistance genes detected in the study populations expressed as either resistance gene 
per one nanogram of DNA or resistance genes per 106 copies of 16S rRNA 





(max2, min3, SD4) 
7075.472 
48250.0, 126.244, 13331. 756  
7658.936 
58750.0, 176.351, 12563.946 
erm(B)/ng DNA 
(max2, min3, SD4) 
434.650 
19458.333, 0.0, 3329.684 
395.876 
22403.846, 0.0, 3511.783 
cfxA/106 16S rRNA 
(max2, min3, SD4) 
11209.068 
48326.180, 516.189, 12512.3021 
14492.107 
47768.595, 640.491,12844.965 
erm(B)/ 106 16S rRNA 
(max2, min3, SD1) 
644.022 
 12424.850, 0.0, 2888.647 
810.459 
13617.767, 0.0, 2575.799 
1: nanogram; 2:Maximum; 3: Minimum; 4: standard deviation 
 
We detected the cfxA and erm(B) in almost all the participants, with cfxA detected in 100% of 
the samples and erm(B) detected in 94%. The values of copy number of resistance genes 
detected in saliva samples per 106 copies of 16S rRNA gene were categorizing as low, 
medium or high presence of resistance genes. Samples with copy number between 1 and 9999 
were classified as low. On the other hand, the copy number between 10000 and 29999 was 
categorised as medium while samples with a copy number of 30000 or above were classified 
as high. According to this classification, the distribution of the cfxA gene in the low, medium 
and high group, were 32 (39%), 36 (43%) and 15 (18%), respectively. For erm(B) resistance 
gene, 75 of the samples (90%)  with erm(B) were classified as low, and 3 samples (4%) as 
medium. None of the samples had erm(B) copy number higher than 30000 per 106 copies of 
16S rRNA gene. 
 
Table 5. Percentage of samples categorised as low, medium and high presence of resistance gene per 106 copies 
of 16s rRNA. 
Gene 
Low (1-9999 copies)* Medium (10000-29999 copies)* High (≥30000 copies)* 
cfxA 32 (39%) 36 (43%) 15 (18%) 
erm(B) 75 (90%) 3 (4%) - 
* copy number of resistance genes per 106 copies of 16S rRNA 
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Figure 10. Histograms of logtransformated relative copy numbers of cfxA resistance 
genes/ 16S rRNA in 1st year students and 5th-year students. 
 
 
Figure 11. Histograms of logtransformated relative copy numbers of cfxA resistance 
genes/ nanogram DNA in 1st year students and 5th year students. 
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Figure 12. Histograms of logtransformated relative copy numbers of erm(B) 
resistance genes/ 16S rRNA in 1st- and 5th-year students. 
 
Figure 13. Histograms of logtransformated realative copy numbers of erm(B) 
resistance genes/ nanogram DNA in 1st year students and 5th year students. 
 
Using regression analysis, we found an association between the numbers of resistance genes 
of erm(B) per ng/DNA and the use of 3-10 courses of antibiotics throughout life (p=0,035). 
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The use of more than 10 courses of antibiotics throughout life showed an even more 
significant association with the detected erm(B) gene copies in the saliva (p=0,005).  
Furthermore, we also found a significant association between the use of more than 10 courses 
of antibiotics and the level of resistance genes erm(B) per 16S rRNA (p=0,022).  
10. Discussion 
The most commonly prescribed antibiotic in dental practice in Norway is 
phenoxymethylpenicillin (72% of total prescriptions)(7). Dentists in Norway also prescribe 
other antibiotics. These include, but not limited to, erythromycin, metronidazole and 
tetracycline (8).  
 
The aim of the study was to investigate the occurrence of selected antimicrobial resistance 
genes to some of the mostly prescribed antibiotics in dental practice in Norway. In the current 
study, saliva samples were obtained from dental students to investigate the presence of cfxA 
and erm(B) genes that are responsible for phenoxymethylpenicillin and erythromycin 
resistance, respectively. In addition, we aimed to assess if there is any relationship between 
the prevalence of these genes and their levels (counts) in the saliva and being a working 
dentist, hygiene and infection control practices at the clinic, and any other related parameters 
revealed by the participants in the questionnaire, for example, history and frequency of the 
use of antibiotics in the past.  
 
Although, antibiotic prescription in dentistry is much lower than that in medical practice, but 
resistant oral bacteria have been reported to be an increasing problem. Antibiotic resistance 
genes found in oral bacteria include these encode for multi-drug efflux pumps and resistance 
genes to aminoglycosides, β-lactams, bacitracin, and macrolides and tetracycline (41-45).  
Resistance to β-lactams antibiotics in oral bacteria is mainly mediated by the production of β-
lactamases enzymes by bacteria. Several genes have been implicated for β-lactamase 
production among oral bacteria. The most reported β-lactamase-producing genes among oral 
isolates are cfxA genes (cfxA1, cfxA2 and cfxA3) that produce broad-spectrum β-lactamases 
(46, 47).  On the other hand, erythromycin resistance genes that have been reported in oral 
bacteria include erm and mef genes (44, 48). 
 
In our study, we compared the prevalence and levels of cfxA and erm(B) resistance genes in 
saliva samples obtained from 41 and 42 individuals recruited from 1st- and 5th-year dental 
Christensen and Sørensen 2016 Investigation of cfxA and erm(B) in Saliva Samples 
 31 
students, respectively. In our study, we use 16S rRNA gene copy number as a representative 
of total bacterial counts in saliva samples. However, the 16S rRNA copy number per genome 
varies from one bacterial species to another. Therefore, the absolute counts of resistances 
genes were reported per 106 copies of 16S rRNA gene rather than bacterial cell numbers.  
Although our original thought was that there might be significant differences between the two 
groups based on exposure to patients during clinical practice, however, our result suggests 
otherwise. It might be that our sample size is small to detect differences in the level of 
resistant genes between the two groups. If any real difference exists between the two groups it   
would probably be revealed with a greater number of participants in each group. If dental 
practice could be considered as a risk factor for getting resistance bacteria from the working 
environment, then another factor that might mask this effect in our study, if any, is the time 
needed  for the resistance genes to establish themselves permanently in the oral microbiome. 
Therefore, a total of 18 months of work in the dental clinic may be insufficient for resistance 
genes to be stable in the oral microbiome. Thus, it would be interesting to conduct a study 
with a population of dentist with many years of experience in treating patients.  
 
When comparing our results with other studies in the literature, a challenge has been the lack 
studies with similar methodology. In fact, our study is the first, to the best of our knowledge, 
which report the copy number of resistance genes in saliva samples. The ddPCR is a relatively 
new method of gene quantification but it will certainly become more frequently used by other 
researchers in the coming years.  
 
When comparing presence of resistance genes in saliva samples between 1st- and 5th-year 
students, we found no significant difference in the level of resistance genes between the two 
groups. Resistance genes of both types cfxA and erm(B) were present in, 100% and 94%, 
respectively, of the samples. In a previous study to investigate the prevalence of erythromycin 
resistant oral bacteria, 7% of cultivable oral bacteria were found to be resistant (48). In 
another study from Norway the overall proportion of ampicillin and metronidazole resistance 
among 18 identified oral species were 7.9% and 11.3%, respectively (49).   
 
Our results show that the level of cfxA in the saliva samples is approximately 17 times higher 
compared to the level of the erythromycin resistance genes erm(B). This could be explained, 
at least in part, to the human high proportion of use of β-lactam antibiotics in most society. In 
Norway, penicillins are the first choice for treatment when getting bacterial infectious 
Christensen and Sørensen 2016 Investigation of cfxA and erm(B) in Saliva Samples 
 32 
diseases that required antibiotic prescription (8). It should be logical to assume that factors 
that influence the accumulation of more resistance genes in oral bacteria is not limited to the 
systematic use of antibiotics for the treatment of oral infections but also when we use these 
drugs for the treatment of other infections in the body. Hence, people who had used 3-10 
courses of antibiotics throughout life for any purpose showed higher copy numbers of erm(B) 
per one ng of DNA.   
10.1. Conclusion 
This is the first study in Norway that investigated the presence and levels of antibiotic 
resistance genes, namely cfxA and erm(B) in saliva samples. Although higher levels of 
resistance genes were found in 5th-year students compared to that in the 1st-year students, this 
was not found to be statistically significant. Therefore, we could not conclude that working in 
a dental clinic can be considered a risk factor for getting more antibiotic resistance 
genes.  However, it seems that the use of saliva as a biological sample companied with the 
sensitivity of the ddPCR could be used as a quick microbiological assay in the future to reveal 
the presence and levels of resistance genes in a given individual.  It also seems that the high 
levels of cfxA we found in saliva compared to that of erm(B) reflect the community use of β-
lactam antibiotics where β-lactam antibiotics are the mostly prescribed antibiotics for human 
use. Dentists together with doctors are responsible for antibiotic prescription, and thereby 
both contribute to the total national consumption of these drugs. As health professionals, 
dentists are playing an important role by restricting the wide distribution and preventing 
inappropriate use of antibiotics. 
 
A future follow up of this study is to determine the threshold level of a particular resistance 
gene in the saliva that would predict a failure in antibiotic treatment. As we know, the 
presence of resistant genes could threaten the effectiveness of antibiotic therapy. Therefore, it 
would be tempting to design a future study to link failure of empirical antibiotic therapy to the 
levels of antibiotic resistance genes that could be detected in the saliva.  
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denne	 tiden	 skal	 du	 fortrinnsvis	 ikke	 snakke,	 men	 konsentrere	 deg	 om	 å	 roe	 ned	 kroppen.	 Eventuelle	
tannproteser	beholdes	 i	munnen.	Parafinvoks	 (smakløs	«kloss»)	 tygges	 i	 30	 sek.	 slik	 at	den	blir	myk.	 Spyttet	
svelges	før	testen	begynner.	Deretter	må	du	IKKE	svelge	mens	du	samler	spytt.	Du	skal	tygge	under	hele	testen	
(5	 min),	 som	 om	 du	 spiser	 mat,	 litt	 på	 hver	 side.	 Du	 skal	 spytte	 regelmessig	 i	 et	 oppsamlingsbeger	 med	


































































































1  Kvinne 
2  Mann 
 
 





3. Hvilket studieår/arbeidsfunksjon er du i? 
1  1. studieår (odontologi) 
2  5. studieår (odontologi) 
3  Klinisk veileder (studentklinikken, IKO) 
 
 
4. Hvordan er din generelle helsetilstand nå? 
1  Svært god 
2  God 
3  Verken god eller dårlig 
4  Ikke helt god 
5  Dårlig 
 
 
5. De siste to årene – har du ofte vært syk? 
1  Aldri syk 
2  En sjelden gang 
3  En gang i mellom 
4  Ofte syk 
5  Flere ganger alvorlig syk  
 
 
6. Hvordan er din tannhelse nå? 
1  Svært god 
2  God 
3  Verken god eller dårlig 
4  Ikke helt god 
5  Dårlig 
 
7. Er du fornøyd med utseende til tennene dine? 
1  Svært fornøyd  
2  Noen lunde fornøyd 
3  Temmelig misfornøyd 
4  Svært misfornøyd 
 
 
8. Bruker du medikamenter/medisiner daglig? 









9. Har du tatt antibiotika i løpet av de siste 3 
månedene? 
1  Ja 
2  Nei 
3  Usikker 
 
 
10. Hvor mange ganger gjennom livet har du tatt en 
antibiotika-kur? 
1  Aldri 
2  1-2 ganger 
3  3-10 ganger 
4  Mer enn 10 ganger 
 
 
11. I hvilken grad er du plaget med: 
                                              (1:aldri –--------- 4:svært mye) 
                                                                (1)        (2)          (3)            (4) 
 
Føler du at du ofte er tørr i  
munnen?          
Føler du deg tørr i munnen 
når du spiser?          
Har du ofte problemer  
med kjeveleddet?          






12. De 5 påstandene nedenfor refererer til hvordan du har følt deg i løpet av de siste 2 ukene.  
(Sett en ring ved hver påstand – rundt det tallet som passer best for deg) 
 






















































































15. Har du en kronisk sykdom som innebærer at du 
jevnlig må ha medikamentell behandling? 
(Antibiotika eller annen medisin) 
1  Ja 
2  Nei 
3  Usikker 
 
 
16. Røyker du? Om ja, hvor ofte? 
1  Røyker hver dag 
2  Røyker av og til 
3  Røyker aldri 
 
 
17. Hvor lenge har du røykt? 
1  Jeg røyker ikke 
2  Mindre enn i 3 år 
3  I 3 eller flere år 
 
 
18. Snuser du? Om ja, hvor mye? 
1  Snuser hver dag 
2  Snuser av og til 
3  Snuser aldri 
 
 
19. Hvor lenge har du snust? 
1  Jeg snuser ikke 
2  Mindre enn i 3 år 















21. Hvor ofte pusser du tennene dine? 
1  Morgen og kveld 
2  En gang per dag 
3  En gang i blant 
 
 
22. Hvor ofte bruker du tanntråd/tannstikker? 
1  Etter hver tannpuss 
2  En gang per dag 
3  En gang per uke 
4  Sjeldnere 
5  Aldri 
 
 
23. Hvor ofte vasker du hendene dine (i klinikken)? 
(Merk: her kan du gi flere svar) 
1  Etter telefonbruk 
2  Etter å ha skrevet journal 
3  Etter å ha tatt røntgenbilde 
4  Etter hver pasient 
5  Før hver pasient 







24. Anser du at tannleger er under større risiko for 
smittespredning enn «folk flest»? 
1  Ja, mer enn de fleste  
2  Som «folk flest» 
3  Nei, mindre enn de fleste 
4  Vanskelig å besvare 
 
 
25. Hvem er mest utsatt for smitte på et 
tannlegekontor? 
1  Tannlegen 
2  Pasienten 
3  Tannhelsesekretæren 
4  Vanskelig å besvare 
 
 
26. Kjenner du til/har hørt om tilfeller der en 
pasient har blitt smittet etter et tannlegebesøk? 
1  Ja 
2  Nei 
 
 
27. Kjenner du til/har hørt om tilfeller der 
tannlegen har blitt smittet på tannlegekontoret? 
1  Ja 
2  Nei 
 
 
28. Tenker du at tannlegen kan beskytte seg mot 
smitte? 
1  I svært stor grad 
2  I stor grad 
3  Usikker 
4  I liten grad 
5  Overhode ikke 
 
 
29. Hva er det viktigste enkelt-tiltaket mot smitte? 
1  Unngå nærkontakt med pasient (dråpesmitte) 
2  God håndhygiene 
3  Engangsartiklene  
4  God rengjøring av utstyr 
5  Sikre rutinger for å deponere klinisk avfall 







30. På hvilken måte kan tannlegen beskytte seg når 
han/hun har en «vanlig» pasient i stolen?  
(Merk: her kan du gi flere svar) 
1  Sprite alle arbeidsflater mellom hver pasient 
2  Godt såpe-håndvask mellom hver pasient  
3  Godt håndvask med sprit mellom hver pasient  
4  Ved å bruke engangsartikler som munnbind, 
          hansker, kofferdam, plastfolie etc. 
5  Ved å avstå fra å bruke f.eks. «air-rotor»  
6  Ved å bruke spesielt egnet arbeidstøy  
7  Ved å bruke øyebeskyttelse/ visir  
8  Ved å bruke papirservietter og plast-hetter  
9  Ved å alltid bruke assistent ved stolen  
10  Ved å alltid spyle igjennom vann i treveis- 
           sprøyten og drikkevannslangen før neste 
           pasient 
11  Ved å alltid la pasienten skylle munnen i ca. 
           1 minutt med munnskyllevæske 
12  Ved å ikke berøre pasienten uten verneutstyr  
13  På annen måte 
14  Tannlegen kan ikke beskytte seg mot smitte 
15  Vanskelig å besvare 
 
 
31. Kan tannlegen eliminere smitterisiko ved å 
følge «hygieneveilederen»? 
1  Ja 
2  Nei 
3  Vanskelig å besvare 
 
 
32. Hva er viktige barrierer for god hygiene på 
tannklinikken? 
1  Glemsomhet 
2  Behandlingen tar lengre tid 
3  Ubekvemme arbeidsforhold 
4  Manglende kunnskap om smittevern 


















33. Hvilken metode ville du benyttet for å reingjøre de forskjellige redskapene?  
(Sett en ring rundt det tallet som passer best for deg) 
 













































B Rotkanalinstrumenter 1 2 3 4 5 6 7 
C Håndstykker (bor) 1 2 3 4 5 6 7 
D Avtrykk 1 2 3 4 5 6 7 
E Undersøkelses brett 1 2 3 4 5 6 7 
F Skarpe instrumenter 1 2 3 4 5 6 7 
G Kirurgisk utstyr 
 




34. I hvilke situasjoner ville du brukt de nedenfor nevnte hjelpemidlene?  
(Sett en ring rundt det tallet som passer best for deg) 
 








































B To par hansker 1 2 3 4 5 6 
C Munnbind 1 2 3 4 5 6 
D Øyebeskyttelse 1 2 3 4 5 6 
E Visir 1 2 3 4 5 6 
F Engangsartikler 1 2 3 4 5 6 
G Plast over hele stolen 1 2 3 4 5 6 
H Plast også på tastatur, lampe, blyant, etc 
 





TAKK FOR DINE SVAR! 
